Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools; S 2355, Patients Deserve Price Tags
Literal federal measure citations: S 2355
2026 · 2nd Quarter (Apr 1 - June 30)
CARIS SCIENCE INC
Filed by SPLITOAK STRATEGIES LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 21, 2026
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- SPLITOAK STRATEGIES LLC
- Client
- CARIS SCIENCE INC
- Filing UUID
- 5e079b42-4484-4914-b4c8-1e41efc300ad
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Role of molecular profiling in cancer care; access to molecular profiling technologies in Medicare; prior authorization reform in Medicare and appropriate reimbursement for cutting edge cancer diagnostic testing.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.